1. Home
  2. SUPN vs GLOB Comparison

SUPN vs GLOB Comparison

Compare SUPN & GLOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$55.61

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo Globant S.A.

GLOB

Globant S.A.

HOLD

Current Price

$51.88

Market Cap

2.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUPN
GLOB
Founded
2005
2003
Country
United States
Luxembourg
Employees
N/A
30084
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.2B
IPO Year
2010
2015

Fundamental Metrics

Financial Performance
Metric
SUPN
GLOB
Price
$55.61
$51.88
Analyst Decision
Strong Buy
Buy
Analyst Count
5
14
Target Price
$61.60
$79.14
AVG Volume (30 Days)
740.4K
1.7M
Earning Date
05-21-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$392,755,000.00
N/A
Revenue This Year
$23.19
$3.35
Revenue Next Year
$17.65
$5.52
P/E Ratio
N/A
$22.55
Revenue Growth
N/A
N/A
52 Week Low
$29.16
$40.77
52 Week High
$59.68
$145.46

Technical Indicators

Market Signals
Indicator
SUPN
GLOB
Relative Strength Index (RSI) 63.79 47.09
Support Level $47.95 $40.77
Resistance Level $58.67 $71.47
Average True Range (ATR) 2.26 3.04
MACD 0.38 0.84
Stochastic Oscillator 60.13 75.18

Price Performance

Historical Comparison
SUPN
GLOB

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

About GLOB Globant S.A.

Globant is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2003 in Argentina but is currently headquartered in Luxembourg and primarily serves clients in the US and Latin America. Globant's client base is relatively concentrated in the media and entertainment and financial services industries.

Share on Social Networks: